John Sampson, MD, PhD, MBA, MHSc, chair of the Department of Neurosurgery, discusses how the Duke Cancer Institute is studying DNA and genetics with the goal of creating each individual's unique cancer "fingerprint" to offer targeted therapies.
Read Full Story